%0 Journal Article %T 参松养心胶囊治疗阵发性心房颤动的研究进展
Research Progress in the Treatment of Paroxysmal Atrial Fibrillation with Shensongyangxin Capsule %A 江昊 %J Journal of Clinical Personalized Medicine %P 1043-1051 %@ 2334-3443 %D 2025 %I Hans Publishing %R 10.12677/jcpm.2025.42276 %X 心房颤动(atrial fibrillation, AF)，简称房颤，是临床上最常见的心律失常之一，也是心房电生理活动严重紊乱的类型之一，常导致患者出现包括血栓栓塞、心功能不全等严重并发症，危及患者自身生命并严重影响其生活质量。根据相关流行病学调查表明中国目前的AF患者约有1200万，且随着年龄的增大，发病率及死亡率呈逐年上升的趋势。阵发性心房颤动(paroxysmal atrial fibrillation, PAF)因其发作时间短以及症状不明显常被患者忽略，待出现AF相关并发症时已为时已晚。既往对于阵发性心房颤动的治疗，传统的治疗方法虽然能够缓解患者的某些临床症状，但其疗效具有一定的局限性。近年来，中成药物在心律失常的预防、治疗以及相关机制研究方面都取得了显著进展。参松养心胶囊在基础和临床研究方面已显示出对多种心律失常的良好疗效，国内众多指南亦将其纳入治疗心律失常的常规推荐方案。本文的目的在于概述参松养心胶囊在治疗阵发性心房颤动方面的研究进展。
Atrial fibrillation (AF) is one of the most common arrhythmias in clinical practice and one of the types of serious disturbances in atrial electrophysiologic activity, which often leads to serious complications including thromboembolism and cardiac insufficiency, jeopardizing patients’ lives and seriously affecting their quality of life. According to relevant epidemiologic surveys, there are about 12 million AF patients in China, and the morbidity and mortality rates are increasing with age. Paroxysmal atrial fibrillation (PAF) is often overlooked by patients because of its short attack time and insignificant symptoms, and it is too late for AF-related complications to occur. In the treatment of paroxysmal atrial fibrillation, although traditional therapies can alleviate some clinical symptoms, their efficacy has certain limitations. In recent years, Chinese patent medicines have made significant progress in the prevention and treatment of arrhythmia as well as in the study of related mechanisms. Shensongyangxin capsule has shown good efficacy in basic and clinical studies for a variety of arrhythmias, and many domestic guidelines have also included it in the routine recommendation for arrhythmia treatment. The purpose of this article is to summarize the research progress in the treatment of paroxysmal atrial fibrillation with Shensongyangxin capsule. %K 参松养心胶囊， %K 阵发性心房颤动， %K 综述
Shensongyangxin Capsule %K Paroxysmal Atrial Fibrillation %K Review %U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=111617